Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-11
1997-07-22
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514615, A61K 3117
Patent
active
056504411
ABSTRACT:
Antiviral compositions useful for the inhibition of HIV include various azo dye compounds which have the ability of inhibiting the binding of HIV rgp120 to CD4 cells on peripheral blood lymphocytes and affecting HIV replication. Also disclosed are methods for treating HIV viral infections with these compositions.
REFERENCES:
Akerfeldt et al J. Med Chem vol. 14(7) 1971 pp. 596-600.
Balzarini et al 104CA:199769b 1986.
Schols et al 110CA:228460a 1989.
Aszalos Adorjan
Pine P. Scott
Weaver James C.
The United States of America as represented by the Secretary of
Travers Russell
LandOfFree
Method of assaying CD4 glycoproteins by using certain azo dyes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of assaying CD4 glycoproteins by using certain azo dyes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of assaying CD4 glycoproteins by using certain azo dyes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1560338